suvorexant


SMILES Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1
InChIKey JYTNQNCOQXFQPK-MRXNPFEDSA-N

Chemical properties

Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 3
Molecular weight (Da) 450.2

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
OX1 OX1R Human Orexin A pKi 8.7 9.1 9.3 Guide to Pharmacology
OX2 OX2R Human Orexin A pKi 8.9 9.3 9.5 Guide to Pharmacology
OX2 OX2R Rat Orexin A pKi 9.0 9.0 9.0 Guide to Pharmacology
OX1 OX1R Mouse Orexin A pKi 8.77 8.77 8.77 ChEMBL
OX2 OX2R Mouse Orexin A pKi 8.06 8.06 8.06 ChEMBL
OX1 OX1R Human Orexin A pKi 8.51 9.14 9.4 ChEMBL
OX2 OX2R Human Orexin A pKi 7.93 9.06 9.46 ChEMBL
OX1 OX1R Human Orexin A pKi 8.03 8.03 8.03 Drug Central
OX2 OX2R Human Orexin A pKi 8.02 8.02 8.02 Drug Central
OX2 OX2R Mouse Orexin A pKi 8.09 8.09 8.09 Drug Central
OX1 OX1R Mouse Orexin A pKi 8.06 8.06 8.06 Drug Central
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
OX1 OX1R Human Orexin A pKB 8.7 8.7 8.7 Guide to Pharmacology
OX2 OX2R Human Orexin A pKB 9.5 9.5 9.5 Guide to Pharmacology
OX1 OX1R Mouse Orexin A pKB 9.0 9.0 9.0 Guide to Pharmacology
OX1 OX1R Rat Orexin A pKB 9.2 9.2 9.2 Guide to Pharmacology
OX2 OX2R Rat Orexin A pKB 9.2 9.2 9.2 Guide to Pharmacology
OX2 OX2R Mouse Orexin A pKB 8.3 8.3 8.3 Guide to Pharmacology
OX1 OX1R Human Orexin A pIC50 6.7 7.15 7.3 ChEMBL
OX2 OX2R Human Orexin A pIC50 6.86 7.6 9.4 ChEMBL